TROG Cancer Research
Members Login   CQMS Login

Subspecialty Working Parties

The primary role of the subspecialty working parties is to advise the TROG Scientific Committee (TSC) on current trials and projects in the subspecialty research portfolio, on any gaps in research activities, on new research concepts including the scientific merit of the proposal and on the research priorities to be adopted by TROG. Please see the Working Party Terms of Reference for more detailed information.

The Subspecialty Working Parties will represent radiation oncology, medical physics, radiation therapy, statistics, consumers and other appropriate disciplines (e.g. medical oncology, allied health).

If you are interested in joining a working party please complete an Expression of Interest form. 

Contact the TROG office on +61 2 40143911 | committees@trog.com.au  if you would like further information on joining a Working Party. 


Breast Working Party

Chair: Boon Chua

Group contact:
Tamica Humby

TROG Central Office
Phone: +61 2 4014 3905
Email: committees@trog.com.au


Genitourinary Working Party

Chair: David Pryor 

Group contact:
Oliva Cook
TROG Central Office
Phone: +61 2 4014 3918
Email: committees@trog.com.au


Head, Neck and Skin Working Party

Chair: June Corry

Group contact:
Patrick Wheeler
TROG Central Office
Phone: +61 2 4014 3903
Email: committees@trog.com.au


Lung Working Party

Chair: Fiona Hegi-Johnson

Group contact:
Annette Dempsey
TROG Central Office
Phone: +61 2 4014 3916
Email: committees@trog.com.au


Neuro-Oncology Working Party

*In late 2019 the TROG membership expressed a need for a Neuro-oncology Working Party to be developed. If you are interested in joining this committee, please complete the Expression of Interest form.     

Chair: To be appointed 

Group contact:
TBA
TROG Central Office
Phone: +61 2 4014 3911
Email: committees@trog.com.au

TROG conducts world-class research in radiotherapy-based clinical trials.


Latest News

  • 01 Apr 2020

    The coronavirus health pandemic is a challenging time for us all – personally and professionally. We know that the changes and safety precautions required as a result of the pandemic have had significant impacts on the way we operate clinical trials – those that are underway, set t...

  • 20 Mar 2020

    The situation around the COVID-19 pandemic is rapidly changing. Like many other businesses, TROG Cancer Research is adapting to this situation to ensure the safety and welfare of staff, whilst aiming to limit interruptions to our business operations. Some of those measures inclu...

  • 15 Jan 2020

    _ src="/sitefiles/trogcomau/fbp_0378_large.jpg" /> new research by the university of new south wales (unsw), presented at the clinical oncology society of australia’s (cosa) annual scientific meeting (asm) found that increased use of radiation therapy for prostate cancer patients c...

  • 13 Sep 2019

    trog cancer research will work with clinicians at townsville hospital, as well as other national experts, to implement a research program aimed at understanding how to best use new mri linac technology to benefit cancer patients. img src="/sitefiles/trogcomau/tro_trog_cancer_resear...

  • 09 Sep 2019

    TROG Cancer Research is currently in the final year of their 2017-2019 strategic plan. On Friday 2 August 2019, we held a strategic planning meeting with key stakeholders to discuss the direction and focus for the upcoming three years.  The workshop facilitated by Ms Alison Evans, Hea...

  • 03 Sep 2019

    trog cancer research are proud to announce that we have two new additions to the trog cancer research board of directors. joining our team is professor annette haworth and denis byron. appointed as a non-radiation oncology director, annette is an accredited medical physicist wh...